DIR 020 and DIR 021 annual reports
DIR-108 annual report
Correspondence about a query on the regulation of null segregants, topics for a presentation
and publishing a presentation provided by the OGTR.
This letter lays out the Minister's expectations of the Gene Technology Regulator.
These documents support the Risk Assessment and Risk Management Plans (RARMPs) prepared for applications for dealings involving intentional release (DIRs) of GMOs into the environment. They address matters common to many DIR risk assessments and are referred to in relevant RARMPs.
Gene Technology (Equine Influenza Vaccine) Emergency Dealing Extension Determination 2008
This impact statement assesses the changes recommended by the 2016-19 Technical Review of the Gene Technology Regulations.
This application form must be used for applications for a licence for dealings (activities) NOT involving the intentional release of a GMO into the environment (DNIR).
The Gene Technology Regulator may invoke these guidelines when determining licence and certification conditions.
Use this form to apply for a declaration that specified information is confidential commercial information (CCI) under the Gene Technology Act 2000.